AMSF Q2 2026 Earnings Call Summary | Stock Taper
Logo
AMSF

AMSF — AMERISAFE, Inc.

NASDAQ


Q2 2026 Earnings Call Summary

July 22, 2026

AMERISAFE Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

  • Net Income: $14.6 million ($0.78 per diluted share), up from $14 million ($0.73 per diluted share) in Q2 2025.
  • Operating Net Income: $8.3 million ($0.44 per diluted share), down from $10 million ($0.53 per diluted share) in Q2 2025.
  • Gross Written Premiums: Increased 7.9% to $86 million from $79.7 million.
  • Net Premiums Earned: Increased 11.4% to $77.3 million from $69.4 million.
  • Expense Ratio: 31.8%, slightly up from 31.3% due to a one-time bad debt write-off of approximately $700,000.
  • Return on Average Equity: 23.5%.
  • Investment Income: $6.5 million, down 2.4% from the previous year.
  • Statutory Surplus: $200.8 million, down from $217.8 million at year-end 2025.
  • Book Value per Share: Increased to $13.49, a 0.7% increase year-to-date.

2. Strategic Updates and Business Highlights:

  • Continued premium growth for the ninth consecutive quarter, driven by strong renewal retention (over 93%) and favorable audit premium activity.
  • Payroll growth among insureds remains healthy, indicating robust economic activity.
  • AMERISAFE's specialized underwriting in high-hazard industries and disciplined pricing strategies are key differentiators in a competitive market.
  • The company repurchased approximately 181,000 shares at an average price of $30.58, returning $5.6 million to shareholders.

3. Forward Guidance and Outlook:

  • AMERISAFE aims to balance profitable growth, underwriting discipline, and long-term shareholder value creation despite a gradually softening market.
  • The company remains optimistic about its ability to maintain mid-single-digit growth trajectories and strong customer retention.

4. Bad News, Challenges, or Points of Concern:

  • The workers' compensation market is experiencing gradual softening, with rate reductions, increasing medical costs, and heightened competition impacting industry-wide results.
  • Claim frequency has increased, returning closer to 2023 levels, although severity has decreased.
  • The company noted challenges with medical inflation, which is expected to persist, impacting future costs.
  • The competitive landscape is intensifying, with larger players becoming more aggressive, potentially affecting AMERISAFE's growth.

5. Notable Q&A Insights:

  • Management acknowledged increased competition, particularly from package carriers, but did not attribute it solely to larger players.
  • Strong audit activity was highlighted, with wage growth among insureds contributing positively to future audit premiums.
  • The company is focused on retaining profitable accounts and maintaining disciplined pricing strategies amidst competitive pressures.
  • Concerns were raised about medical inflation and its impact on claims, with management emphasizing the importance of adhering to fee schedules to control costs.
  • The discussion included insights on California's recent rate increase and its potential implications for broader market trends, indicating a recognition of rising costs despite ongoing rate reductions in many regions.

Overall, AMERISAFE reported solid financial performance in Q2 2026, but faces ongoing challenges in a competitive and softening market environment.